Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Blood Glucose/drug effects"'
Autor:
Khunti, Kamlesh, Kosiborod, Mikhail, Kim, Dae Jung, Kohsaka, Shun, Lam, Carolyn S.P., Goh, Su Yen, Chiang, Chern En, Shaw, Jonathan, Cavender, Matthew A., Tangri, Navdeep, Franch-Nadal, Josep, Holl, Reinhard W., Jørgensen, Marit Eika, Norhammar, Anna, Eriksson, Johan G., Zaccardi, Francesco, Karasik, Avraham, Magliano, Dianna J., Thuresson, Marcus, Chen, Hungta, Wittbrodt, Eric, Bodegård, Johan, Surmont, Filip, Fenici, Peter, Wilding, John P., Carstensen, Bendix, Kendrick, Rachel, Belli, Wesley, Wittbrodt, Eric T., Noguchi, Yusuke, Andersson-Sundell, Karolina
Publikováno v:
Khunti, K, Kosiborod, M, Kim, D J, Kohsaka, S, Lam, C S P, Goh, S Y, Chiang, C E, Shaw, J, Cavender, M A, Tangri, N, Franch-Nadal, J, Holl, R W, Jørgensen, M E, Norhammar, A, Eriksson, J G, Zaccardi, F, Karasik, A, Magliano, D J, Thuresson, M, Chen, H, Wittbrodt, E, Bodegård, J, Surmont, F, Fenici, P, Kosiborod, M, Cavender, M A, Wilding, J P, Khunti, K, Norhammar, A, Carstensen, B, Holl, R W, Lam, C S P, Kendrick, R, Belli, W, Wittbrodt, E T, Franch-Nadal, J, Noguchi, Y, Karasik, A, Tangri, N, Kohsaka, S, Kim, D J, Shaw, J, Andersson-Sundell, K, Goh, S Y, Chiang, C E, Eriksson, J G, Zaccardi, F, Fenici, P, Bodegård, J & on behalf of the CVD-REAL Investigators and Study Group 2021, ' Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents : analysis of CVD-REAL data ', Cardiovascular Diabetology, vol. 20, no. 1, 159 . https://doi.org/10.1186/s12933-021-01345-z
Cardiovascular Diabetology, 20(1):159. BioMed Central Ltd.
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-15 (2021)
Cardiovascular Diabetology
CARDIOVASCULAR DIABETOLOGY
Cardiovascular Diabetology, 20(1):159. BioMed Central Ltd.
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-15 (2021)
Cardiovascular Diabetology
CARDIOVASCULAR DIABETOLOGY
Background Randomized, controlled cardiovascular outcome trials may not be fully representative of the management of patients with type 2 diabetes across different geographic regions. We conducted analyses of data from the multinational CVD-REAL cons
Autor:
D. Elleri, Malgorzata E. Wilinska, Sabine E. Hofer, Thomas R. Pieber, Fiona Campbell, Sabine Arnolds, Carine de Beaufort, Amy Criego, David B. Dunger, Thomas Kapellen, Elke Fröhlich-Reiterer, Roman Hovorka, Birgit Rami-Merhar, Martin Tauschmann, KidsAP Consortia, Lalantha Leelarathna, Hood Thabit, Carlo L. Acerini, Klemen Dovc, Viral N. Shah, Mark L. Evans, Charlotte K. Boughton, Richard M. Bergenstal, Janet M. Allen, Judy Sibayan, Lia Bally
Publikováno v:
Diabetes Care
APCam11 Consortium, AP@home Consortium & KidsAP Consortia 2019, ' Young Children Have Higher Variability of Insulin Requirements : Observations During Hybrid Closed-Loop Insulin Delivery ', Diabetes Care, vol. 42, no. 7, pp. 1344-1347 . https://doi.org/10.2337/dc18-2625
APCam11 Consortium, AP@home Consortium & KidsAP Consortia 2019, ' Young Children Have Higher Variability of Insulin Requirements : Observations During Hybrid Closed-Loop Insulin Delivery ', Diabetes Care, vol. 42, no. 7, pp. 1344-1347 . https://doi.org/10.2337/dc18-2625
OBJECTIVE: To quantify age-related variability of insulin needs during day and night closed-loop insulin delivery. RESEARCH DESIGN AND METHODS: We retrospectively analyzed data from hybrid closed-loop studies involving young children (1-6 years old,
Publikováno v:
Critical Care Clinics. 35:341-355
In health, postprandial glycemic excursions are attenuated via stimulation of insulin secretion, suppression of glucagon secretion, and slowing of gastric emptying. The incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic p
Autor:
Petrie, John R., Chaturvedi, Nish, Ford, Ian, Hramiak, Irene, Hughes, Alun D., Jenkins, Alicia J., E. Klein, Barbara, Klein, Ron, Ooi, Teik Chye, Rossing, Peter, Sattar, Naveed, Stehouwer, Coen D. A., Colhoun, Helen M., Ford, I, Kean, S, Thomson, E, Gillespie, L, Gibb, J, Greenlaw, N, Hramiak, I, Keech, A, Jenkins, A, Chaturvedi, N, Hughes, A, March, K, Coady, E, Tillin, T, Bots, M, Klein, R, Klein, B, Dreyer, J, Jan, T, Meuer, S, Murach, D, Sheffy, Koby, Lusky, Ravit, Peleg, S, Petrie, J, Colhoun, H, Shore, A, Carty, D, Donnan, P, Witham, M, Adler, A, Lonn, E, Rauchhaus, P, Lindsay, R, Brouwers, M, Van‐Melckebeke, J, Hamill, T, Cuthbertson, L, Murray, A, Jolly, L, Miller, E, Sattar, N, Hair, J, Bell, A, Carmichael, S, Douglas, E, Surtees, P, Dinnett, E, Allan, J, Watson, C, McLaughlin, M, Brindley, G, Smillie, E, Motherwell, D, MacDonald, S, Ellis, P, Stuart, D, Travers, M, Brearley, S, Greig, L, Haw, J
Publikováno v:
Petrie, J R, Chaturvedi, N, Ford, I, Hramiak, I, Hughes, A D, Jenkins, A J, E Klein, B, Klein, R, Ooi, T C, Rossing, P, Sattar, N, Stehouwer, C D A, Colhoun, H M & REMOVAL Trial Team 2017, ' Metformin in adults with type 1 diabetes : Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial ', Diabetes, Obesity and Metabolism, vol. 19, no. 4, pp. 509-516 . https://doi.org/10.1111/dom.12840
Diabetes, Obesity & Metabolism, 19(4), 509. Wiley-Blackwell
2017, ' Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial ', Diabetes, Obesity and Metabolism, vol. 19, no. 4 . https://doi.org/10.1111/dom.12840
Diabetes, Obesity & Metabolism
Diabetes Obesity & Metabolism, 19(4), 509-516. Wiley
Diabetes, Obesity & Metabolism, 19(4), 509. Wiley-Blackwell
2017, ' Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial ', Diabetes, Obesity and Metabolism, vol. 19, no. 4 . https://doi.org/10.1111/dom.12840
Diabetes, Obesity & Metabolism
Diabetes Obesity & Metabolism, 19(4), 509-516. Wiley
Aims: Cardiovascular (CV) disease is a major cause of reduced life expectancy in type 1 diabetes (T1D). Intensive insulin therapy prevents CV complications but is constrained by hypoglycaemia and weight gain. Adjunct metformin reduces insulin dose re
Autor:
Azra Kurbasic, Femke Rutters, Markku Laakso, Joline W.J. Beulens, Caroline Brorsson, Mark Walker, Tarja Kokkola, Emmanouil T. Dermitzakis, Gary Frost, Andrew T. Hattersley, Hartmut Ruetten, Søren Brunak, Simone P. Rauh, Federico De Masi, Ramneek Gupta, Imre Pavo, Christopher J. Groves, Jerzy Adamski, Andrea Tura, Bernd Jablonka, Alison Heggie, Tue H. Hansen, Ana Viñuela, Martin Ridderstråle, Andrea Mari, Jane Kaye, Henrik Vestergaard, Robert W. Koivula, Kristine H. Allin, Harriet Teare, Michelle Hudson, Thomas E. White, Jochen M. Schwenk, Mark I. McCarthy, Maritta Siloaho, Mandy H Perry, Ewan R. Pearson, Oluf Pedersen, Ian M Forgie, Timothy J. McDonald, Soren Brage, Anubha Mahajan, E. Louise Thomas, Paul W. Franks, Anitra D.M. Koopman, Philippe Froguel, Torben Hansen, Jimmy D. Bell, Giuseppe N. Giordano, Adem Y. Dawed
Publikováno v:
Koivula, R W, Forgie, I M, Kurbasic, A, Viñuela, A, Heggie, A, Giordano, G N, Hansen, T H, Hudson, M, Koopman, A D M, Rutters, F, Siloaho, M, Allin, K H, Brage, S R, Brorsson, C A, Dawed, A Y, de Masi, F, Groves, C J, Kokkola, T, Mahajan, A, Perry, M H, Rauh, S P, Ridderstråle, M, Teare, H J A, Thomas, E L, Tura, A, Vestergaard, H, White, T, Adamski, J, Bell, J D, Beulens, J W, Brunak, S R, Dermitzakis, E T, Froguel, P, Frost, G, Gupta, R, Hansen, T, Hattersley, A, Jablonka, B, Kaye, J, Laakso, M, McDonald, T J, Pedersen, O, Schwenk, J M, Pavo, I, Mari, A, McCarthy, M I, Ruetten, H, Walker, M, Pearson, E, Franks, P W & IMI DIRECT Consortium 2019, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 62, no. 9, pp. 1601-1615 . https://doi.org/10.1007/s00125-019-4906-1
Koivula, R W, Forgie, I M, Kurbasic, A, Viñuela, A, Heggie, A, Giordano, G N, Hansen, T H, Hudson, M, Koopman, A D M, Rutters, F, Siloaho, M, Allin, K H, Brage, S, Brorsson, C A, Dawed, A Y, De Masi, F, Groves, C J, Kokkola, T, Mahajan, A, Perry, M H, Rauh, S P, Ridderstråle, M, Teare, H J A, Thomas, E L, Tura, A, Vestergaard, H, White, T, Adamski, J, Bell, J D, Beulens, J W, Brunak, S, Dermitzakis, E T, Froguel, P, Frost, G, Gupta, R, Hansen, T, Hattersley, A, Jablonka, B, Kaye, J, Laakso, M, McDonald, T J, Pedersen, O, Schwenk, J M, Pavo, I, Mari, A, McCarthy, M I, Ruetten, H, Walker, M, Pearson, E, Franks, P W & IMI-DIRECT consortium 2019, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes : descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 62, no. 9, pp. 1601-1615 . https://doi.org/10.1007/s00125-019-4906-1
Diabetologia
Diabetologia, Vol. 62, No 9 (2019) pp. 1601-1615
Diabetologia, 62(9), 1601-1615. Springer Verlag
Diabetologia 62, 1601-1615 (2019)
Koivula, R W, Forgie, I M, Kurbasic, A, Viñuela, A, Heggie, A, Giordano, G N, Hansen, T H, Hudson, M, Koopman, A D M, Rutters, F, Siloaho, M, Allin, K H, Brage, S, Brorsson, C A, Dawed, A Y, De Masi, F, Groves, C J, Kokkola, T, Mahajan, A, Perry, M H, Rauh, S P, Ridderstråle, M, Teare, H J A, Thomas, E L, Tura, A, Vestergaard, H, White, T, Adamski, J, Bell, J D, Beulens, J W, Brunak, S, Dermitzakis, E T, Froguel, P, Frost, G, Gupta, R, Hansen, T, Hattersley, A, Jablonka, B, Kaye, J, Laakso, M, McDonald, T J, Pedersen, O, Schwenk, J M, Pavo, I, Mari, A, McCarthy, M I, Ruetten, H, Walker, M, Pearson, E, Franks, P W & the IMI-DIRECT consortium 2019, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 62, no. 9, pp. 1601-1615 . https://doi.org/10.1007/s00125-019-4906-1
Koivula, R W, Forgie, I M, Kurbasic, A, Viñuela, A, Heggie, A, Giordano, G N, Hansen, T H, Hudson, M, Koopman, A D M, Rutters, F, Siloaho, M, Allin, K H, Brage, S, Brorsson, C A, Dawed, A Y, De Masi, F, Groves, C J, Kokkola, T, Mahajan, A, Perry, M H, Rauh, S P, Ridderstråle, M, Teare, H J A, Thomas, E L, Tura, A, Vestergaard, H, White, T, Adamski, J, Bell, J D, Beulens, J W, Brunak, S, Dermitzakis, E T, Froguel, P, Frost, G, Gupta, R, Hansen, T, Hattersley, A, Jablonka, B, Kaye, J, Laakso, M, McDonald, T J, Pedersen, O, Schwenk, J M, Pavo, I, Mari, A, McCarthy, M I, Ruetten, H, Walker, M, Pearson, E, Franks, P W & IMI-DIRECT consortium 2019, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes : descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 62, no. 9, pp. 1601-1615 . https://doi.org/10.1007/s00125-019-4906-1
Diabetologia
Diabetologia, Vol. 62, No 9 (2019) pp. 1601-1615
Diabetologia, 62(9), 1601-1615. Springer Verlag
Diabetologia 62, 1601-1615 (2019)
Koivula, R W, Forgie, I M, Kurbasic, A, Viñuela, A, Heggie, A, Giordano, G N, Hansen, T H, Hudson, M, Koopman, A D M, Rutters, F, Siloaho, M, Allin, K H, Brage, S, Brorsson, C A, Dawed, A Y, De Masi, F, Groves, C J, Kokkola, T, Mahajan, A, Perry, M H, Rauh, S P, Ridderstråle, M, Teare, H J A, Thomas, E L, Tura, A, Vestergaard, H, White, T, Adamski, J, Bell, J D, Beulens, J W, Brunak, S, Dermitzakis, E T, Froguel, P, Frost, G, Gupta, R, Hansen, T, Hattersley, A, Jablonka, B, Kaye, J, Laakso, M, McDonald, T J, Pedersen, O, Schwenk, J M, Pavo, I, Mari, A, McCarthy, M I, Ruetten, H, Walker, M, Pearson, E, Franks, P W & the IMI-DIRECT consortium 2019, ' Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium ', Diabetologia, vol. 62, no. 9, pp. 1601-1615 . https://doi.org/10.1007/s00125-019-4906-1
Aims/hypothesis Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) Diabetes Research on Patient Stratification (DIRECT) epidemiological cohorts at baseline and follow-up examinations (18, 36 and 48 months of follow-up)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fc5bd3c22959b53a248befc4dd035d
https://research.vumc.nl/en/publications/5fde05e6-dbb5-4b2a-b5e2-07f7e0521b01
https://research.vumc.nl/en/publications/5fde05e6-dbb5-4b2a-b5e2-07f7e0521b01
Autor:
Javad Sharifi-Rad, Miquel Martorell, Shabnum Shaheen, Surjit Sen, Natália Martins, Célia F. Rodrigues, Senem Kamiloglu, Renu Suyal, Bahare Salehi, Hubert Antolak, Lalit Giri, Daniela Calina, Ewelina Pawlikowska, Esra Capanoglu, Farukh Sharopov, Anca Oana Docea, Gizem Catalkaya, Dorota Kregiel, Zeliha Selamoglu, Mehwish Jaffer, Nabil Adrar, Krishnendu Acharya, Arun K. Jugran, Raffaele Capasso
Publikováno v:
Molecules, Vol 24, Iss 10, p 1854 (2019)
Molecules
Molecules
Cucurbita genus has received a renowned interest in the last years. This plant species, native to the Americas, has served worldwide folk medicine for treating gastrointestinal diseases and intestinal parasites, among other clinical conditions. These
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9bc9eee6a6142ba9bc7eba18e9dcf65
https://hdl.handle.net/10216/136336
https://hdl.handle.net/10216/136336
Autor:
Gloria A. Aguayo, Ohad Cohen, Ulrike Schierloh, Cindy De Melo Dias, Katharine D. Barnard, Muriel Fichelle, Carine de Beaufort, Michel Vaillant, Aljosa Celebic
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-6 (2018)
Trials
Trials
Background In attempting to achieve optimal metabolic control, the day-to-day management is challenging for a child with type 1 diabetes (T1D) and his family and can have a major negative impact on their quality of life. Augmenting an insulin pump wi
Autor:
Patji Alnæs-Katjavivi, Anne-Cathrine Staff, Hong Wa Yung, Michaela Golic, Carolyn J.P. Jones, Tatiana El-Bacha, Graham J. Burton
Publikováno v:
Diabetologia
Yung, H-W, Alnæs-Katjavivi, P, Jones, C J P, El-Bacha, T, Golic, M, Staff, A-C & Burton, G J 2016, ' Placental endoplasmic reticulum stress in gestational diabetes : the potential for therapeutic intervention with chemical chaperones and antioxidants ', Diabetologia, vol. 59, no. 10, pp. 2240-50 . https://doi.org/10.1007/s00125-016-4040-2
Yung, H-W, Alnæs-Katjavivi, P, Jones, C J P, El-Bacha, T, Golic, M, Staff, A-C & Burton, G J 2016, ' Placental endoplasmic reticulum stress in gestational diabetes : the potential for therapeutic intervention with chemical chaperones and antioxidants ', Diabetologia, vol. 59, no. 10, pp. 2240-50 . https://doi.org/10.1007/s00125-016-4040-2
Aims/hypothesis The aim of this work was to determine whether placental endoplasmic reticulum (ER) stress may contribute to the pathophysiology of gestational diabetes mellitus (GDM) and to test the efficacy of chemical chaperones and antioxidant vit
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 609-617 (2019)
Background Diabetes mellitus become an epidemic problem throughout the world. Relation of the diabetes with diet is known. Some evidence is reported about mother died and risk of diabetes in babies during the life related with gestational diabetes. T
Autor:
Michael H. Cummings, Gerry Rayman, Emma G. Wilmot, Lalantha Leelarathna, Peter L. Jennings, Ramzi A. Ajjan
Publikováno v:
Ajjan, R A, Cummings, M H, Jennings, P, Leelarathna, L, Rayman, G & Wilmot, E G 2019, ' Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system ', Diabetes and Vascular Disease Research, vol. 16, no. 1, pp. 3-12 . https://doi.org/10.1177/1479164118795252
Continuous glucose monitoring and flash glucose monitoring systems are increasingly used by people with diabetes on multiple daily injections of insulin and continuous subcutaneous insulin infusion. Along with real-time updates on current glucose lev